Skip to content
healthcare.dev
Get a free key

Krystexxa

NDC 75987-058, pegloticase, injection, solution, from Horizon Therapeutics USA, Inc..

Product NDC
75987-058
Status
Listed
Labeler
Horizon Therapeutics USA, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125293
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75987-058 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEGLOTICASE8 mg/50mL

Pharmacologic classes

Urate Oxidase [CS]; Uric Acid-specific Enzyme [EPC]

Package NDCNDC-11Package
75987-058-01759870058011 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6e566303-d93a-4130-b764-25749829aa95

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=75987-058

Use it

Look up 75987-058 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75987-058 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75987-058. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.